Company Analysis
Sign in

Fulgent Genetics, Inc. (FLGT)

Nasdaq: FLGT · Services-Medical Laboratories · El Monte, CA · filing with the SEC since 2016
Full chart Alerts Compare
Grade5.1
◀ Past 4.8● Present 5.7▶ Future 4.5
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

17 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Fulgent Genetics, Inc.’s names, not what it holds today.

Patents granted
17
16 utility, 1 design, 1976 to Dec 31, 2025
Granted in 2025
1
Against 1 in 2024 and 1 in 2023
Applications published
35
3 of them in 2025
Names they are printed under
4
a subsidiary, its own name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals3
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
ANP Technologies, Inc. a subsidiary
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in DE)
16 granted
14 published
ANP Technologies, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
17 published
Fulgent Genetics, Inc. its own name
named as the applicant on its applications, in US
0 granted
4 published
Fulgent Genetics, Inc. its own name
US, as the owner printed on each patent
1 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Aug 26, 202512,396,962Nanoparticles containing a taxane and their usePharmaceuticalsFulgent Genetics, Inc.
Jul 23, 202412,042,561Hydrophobic molecule-induced branched polymer aggregates and their usePharmaceuticalsANP Technologies, Inc.
Oct 31, 202311,801,230Nanoparticles containing a taxane and their usePharmaceuticalsANP Technologies, Inc.
Jun 23, 202010,688,048Hydrophobic molecule-induced branched polymer aggregates and their usePharmaceuticalsANP Technologies, Inc.
Oct 29, 201910,458,916Rapid tests for the detection of inhibitors of enzymes and human exposure to the sameBiotechnologyANP Technologies, Inc.
Apr 30, 201910,274,501Immunogenicity assayAnalysis of biological materialsANP Technologies, Inc.
Apr 17, 20189,944,755Oxazoline polymer compositions and use thereofPharmaceuticalsANP Technologies, Inc.
Dec 26, 20179,850,522One-step rapid assay for the detection of inhibitors of enzymesBiotechnologyANP Technologies, Inc.
Jun 7, 20169,360,477Polymer conjugate enhanced bioassaysAnalysis of biological materialsANP Technologies, Inc.
May 3, 20169,329,187Immunogenicity AssayAnalysis of biological materialsANP Technologies, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 6, 20252025/0339381Nanoparticles Containing a Taxane and their UsePharmaceuticalsFulgent Genetics, Inc.
Jun 19, 20252025/0195443Polymer Nanoaggregate Pharmaceutical Composition and Use ThereofPharmaceuticalsANP Technologies, Inc.
Apr 3, 20252025/0108106NANOENCAPSULATED PHARMACEUTICAL COMPOSITION AND USE THEREOFPharmaceuticalsFulgent Genetics, Inc.
Apr 25, 20242024/0132493IMIDAZOPYRIDINE DERIVATIVES AS STING AGONISTSPharmaceuticalsFulgent Genetics, Inc.
Apr 4, 20242024/0108586Nanoparticles Containing a Taxane and their UsePharmaceuticalsANP Technologies, Inc. · patent 12,396,962 granted from it
Jan 18, 20242024/0016754PHARMACEUTICAL COMPOSITION CONTAINING TAXANE NANOAGGREGATES AND USE THEREOFPharmaceuticalsANP Technologies, Inc.
Jan 4, 20242024/0002383COMPOUNDS AND THEIR USE AS VACCINE ADJUVANTSPharmaceuticalsFulgent Genetics, Inc.
Feb 10, 20222022/0041682TLR9-TARGETED THERAPEUTICSPharmaceuticalsANP Technologies, Inc.
Aug 19, 20212021/0251911Nanoparticles Containing a Taxane and their UsePharmaceuticalsANP Technologies, Inc. · patent 11,801,230 granted from it
Mar 4, 20212021/0059939Hydrophobic Molecule-Induced Branched Polymer Aggregates and their UsePharmaceuticalsANP Technologies, Inc. · patent 12,042,561 granted from it
What it applied for, 2024 to 2025: Pharmaceuticals 7.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton FLGT · research, not advice